Zevin Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Zevin Asset Management's AZN Position: Q3 2026 in Review
Zevin Asset Management reduced its AstraZeneca (AZN) stake by 0.38% in Q3 2026, selling an estimated $37.5K and leaving 58,453 shares worth $9.44M. The position accounts for 1.35% of the portfolio, ranked #30.
Zevin Asset Management first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $12.5M in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Zevin Asset Management held 58,453 shares of AstraZeneca worth $9.44M as of Q3 2026.
- Zevin Asset Management sold 225 AstraZeneca shares in Q3 2026, an estimated $37.5K.
- AstraZeneca made up 1.35% of Zevin Asset Management's portfolio in Q3 2026, its #30 holding.
- Zevin Asset Management first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
- Zevin Asset Management's AstraZeneca position peaked at $12.5M in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Zevin Asset Management's 13F filing for Q3 2026, filed 18 Nov 2026.